Yuling Luo
About Yuling Luo
Founder, Chairman & CEO
Yuling Luo holds the titles of Founder, Chairman, and CEO, illustrating his key leadership roles in the life sciences field. He is recognized as an innovator and serial entrepreneur, having built numerous life science startup companies. His impactful career is marked by the creation and commercialization of cutting-edge technologies that have advanced the industry.
Inventor of RNAscope
Yuling Luo is the inventor of RNAscope, a pivotal molecular detection technology that has set new standards in spatial biology. RNAscope has revolutionized RNA tissue imaging, becoming the gold standard in the field. This innovation highlights Luo's contributions to advancing scientific research and diagnostic methodologies.
Leadership at Advanced Cell Diagnostics
As the leader of Advanced Cell Diagnostics (ACD), Yuling Luo transformed the company from a conceptual stage to a successful product launch and commercialization. His strategic vision and leadership were instrumental in the company's growth and its establishment as a significant player in molecular pathology.
Co-Founder of Panomics and Avida Biomed
Yuling Luo co-founded Panomics, where he served as Vice President and Chief Scientific Officer. Panomics was later acquired by Affymetrix in 2008. Additionally, Luo co-founded Avida Biomed and served as Chairman of the board, guiding the company until its acquisition by Agilent in 2022. These ventures underscore his ability to steer startups to successful exits.
Educational Background in Chemistry and Biochemistry
Yuling Luo received his B.S. in Chemistry from the University of Science & Technology of China and later earned his Ph.D. in Biochemistry from Case Western Reserve University. This strong educational foundation has been crucial in his numerous scientific innovations and leadership roles in the biotechnology sector.